ICU Valuation
SeaStar Medical Holding Corp
$
0.801
- Overview
- Forecast
- Valuation
- Earnings
ICU Relative Valuation
ICU's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ICU is overvalued; if below, it's undervalued.
Historical Valuation
SeaStar Medical Holding Corp (ICU) is now in the Fair zone, suggesting that its current forward PS ratio of 10.37 is considered Fairly compared with the five-year average of -0.84. The fair price of SeaStar Medical Holding Corp (ICU) is between 0.47 to 1.88 according to relative valuation methord.
Relative Value
Fair Zone
0.47-1.88
Current Price：0.78
Fair
-0.53
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
SeaStar Medical Holding Corp. (ICU) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
-0.57
EV/EBIT
SeaStar Medical Holding Corp. (ICU) has a current EV/EBIT of -0.57. The 5-year average EV/EBIT is -1.14. The thresholds are as follows: Strongly Undervalued below -4.95, Undervalued between -4.95 and -3.05, Fairly Valued between 0.76 and -3.05, Overvalued between 0.76 and 2.66, and Strongly Overvalued above 2.66. The current Forward EV/EBIT of -0.57 falls within the Historic Trend Line -Fairly Valued range.
11.03
PS
SeaStar Medical Holding Corp. (ICU) has a current PS of 11.03. The 5-year average PS is 26.95. The thresholds are as follows: Strongly Undervalued below -75.25, Undervalued between -75.25 and -24.15, Fairly Valued between 78.05 and -24.15, Overvalued between 78.05 and 129.15, and Strongly Overvalued above 129.15. The current Forward PS of 11.03 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
SeaStar Medical Holding Corp. (ICU) has a current P/OCF of 0.00. The 5-year average P/OCF is -0.41. The thresholds are as follows: Strongly Undervalued below -2.29, Undervalued between -2.29 and -1.35, Fairly Valued between 0.53 and -1.35, Overvalued between 0.53 and 1.48, and Strongly Overvalued above 1.48. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
SeaStar Medical Holding Corp. (ICU) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
SeaStar Medical Holding Corp (ICU) has a current Price-to-Book (P/B) ratio of 11.43. Compared to its 3-year average P/B ratio of -4.40 , the current P/B ratio is approximately -359.74% higher. Relative to its 5-year average P/B ratio of -6.94, the current P/B ratio is about -264.74% higher. SeaStar Medical Holding Corp (ICU) has a Forward Free Cash Flow (FCF) yield of approximately -102.53%. Compared to its 3-year average FCF yield of -88.48%, the current FCF yield is approximately 15.88% lower. Relative to its 5-year average FCF yield of -88.48% , the current FCF yield is about 15.88% lower.
12.26
P/B
Median3y
-4.40
Median5y
-6.94
-96.33
FCF Yield
Median3y
-88.48
Median5y
-88.48
Competitors Valuation Multiple
The average P/S ratio for ICU's competitors is 7.33, providing a benchmark for relative valuation. SeaStar Medical Holding Corp Corp (ICU) exhibits a P/S ratio of 11.03, which is 50.53% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ICU increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ICU in the past 1 year is driven by Unknown.
People Also Watch
MHUA
Meihua International Medical Technologies Co Ltd
0.405
USD
+4.11%
HOTH
Hoth Therapeutics Inc
1.320
USD
-4.35%
XELB
Xcel Brands Inc
1.410
USD
+24.78%
SQFT
Presidio Property Trust Inc
5.320
USD
-7.48%
RVYL
Ryvyl Inc
0.302
USD
+11.85%
CLWT
Euro Tech Holdings Company Ltd
1.230
USD
+2.50%
TSBX
Turnstone Biologics Corp
0.358
USD
+0.85%
SGMA
SigmaTron International Inc
0
USD
-0.33%
GVH
Globavend Holdings Ltd
5.390
USD
-0.37%
FAQ
Is SeaStar Medical Holding Corp (ICU) currently overvalued or undervalued?
SeaStar Medical Holding Corp (ICU) is now in the Fair zone, suggesting that its current forward PS ratio of 10.37 is considered Fairly compared with the five-year average of -0.84. The fair price of SeaStar Medical Holding Corp (ICU) is between 0.47 to 1.88 according to relative valuation methord.
What is SeaStar Medical Holding Corp (ICU) fair value?
How does ICU's valuation metrics compare to the industry average?
What is the current P/B ratio for SeaStar Medical Holding Corp (ICU) as of Aug 07 2025?
What is the current FCF Yield for SeaStar Medical Holding Corp (ICU) as of Aug 07 2025?
What is the current Forward P/E ratio for SeaStar Medical Holding Corp (ICU) as of Aug 07 2025?